Skip to main content
. 2023 Jul 24;13:11968. doi: 10.1038/s41598-023-39212-4

Figure 7.

Figure 7

The concentration of IGF-2 in the total protein of the homogenized subcutaneous fibrous capsules surrounding the silicon spacer at 6 weeks after pretreatment (GHNF; n = 5, control; n = 6). The concentration of IGF-2 in the GHNF group was significantly higher than that in the control group (*p < 0.05).